Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

Subtotal Parathyroidectomy for Tertiary Hyperparathyroidism: a Case Report and Literature Review

Jang Y, Kim GH, Park JH, Tae K

Despite the correction of secondary renal hyperparathyroidism after successful kidney transplantation, some recipients have persistent hyperparathyroidism due to autonomous hypertrophied parathyroid glands. St. Goar first identified and termed this disease...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Updates of Radioiodine Treatment for Graves' Disease

Jeong SY

Radioiodine (RAI) has been used for the treatment of hyperthyroidism and is usually administered orally as sodium iodide (I-131) in solution or a capsule. However, this results in RAI being...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Medical Treatment of Graves' Disease

Chung HK

Among the three treatment modalities of Graves' disease which include antithyroid drug (ATD), radioactive iodine and surgery, the ATD is most commonly preferred in Korea due to ease of use...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Graves' Ophthalmopathy

Lee JK

Graves' ophthalmopathy (GO) is an autoimmune disease associated with orbital inflammation and fibrosis which can result in lid retraction, soft tissue swelling, and proptosis. Treatment should rely on a thorough...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Differentiated Thyroid Cancer and Radioactive Iodine: Past, Present and Future

Lee J, Jo I

Radioiodine has been known as an important and safe armamentarium in the diagnosis and treatment of differentiated thyroid cancer (DTC) for more than 70 years. The 2015 guidelines from the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Severe Pneumocystis Pneumonia in a Thyroid Cancer Patient Receiving Lenvatinib

Jin MH, Kim WG, Kim TY, Kim WB, Shong YK, Jeon MJ

Lenvatinib is a multitargeted tyrosine kinase inhibitor approved for use in patients with iodine-131–refractory thyroid cancer. The common adverse events of lenvatinib include hypertension, proteinuria, fatigue, and diarrhea. To date,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cancer Immunotherapy Related Endocrine Adverse Effects

Kim H, Cho SW, Park YJ

Cancer immunotherapy has emerged as a promising therapy for a wide variety of tumors. Immune checkpoint inhibitors including anti cytotoxic T lymphocyte antigen 4 (CTLA-4), programmed death 1 (PD-1) and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors Affecting Postoperative Occupational Changes and Sick Leave in Patients with Thyroid Cancer

Park KA, Oh YJ, Chu SH, Lee YS, Chang HS, Park CS

BACKGROUND AND OBJECTIVES: Most thyroid cancers progress slowly, have high survival rates, and have good prognosis. Therefore, the management of patients with thyroid cancer should be viewed from a long-term...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hemi-Thyroidectomy versus Total Thyroidectomy in Patients with Low-Risk Papillary Thyroid Carcinoma Sized 2 cm or Less

Park HS, Lee HS, Sung JH, Hwang HJ, Kim SW, Lee KD

BACKGROUND AND OBJECTIVES: The controversy over the optimal extent of thyroidectomy for papillary thyroid carcinoma (PTC) has persisted over a long time period. Particularly, there is a lack of consensus...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association High-Iodine-Containing Seaweed Soup Consumption after Birth and Subclinical Hypothyroidism in Korean Women: Korea National Health and Nutrition Examination Survey IV (2013–2015)

Kim H, Lee HN, Ha J

BACKGROUND AND OBJECTIVES: This study was to investigate the association between the previous history of seaweed intake after childbirth and subclinical hypothyroidism (SCH) occurrence in Korean women based on the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr